Delivery of a Drug for Medical Use (Mnn: Dioxomethyltetrahydropyricimidine+Chloramphenicol)

RussiaTenders notice for Delivery of a Drug for Medical Use (Mnn: Dioxomethyltetrahydropyricimidine+Chloramphenicol). The reference ID of the tender is 114060819 and it is closing on 07 Feb 2025.

100% Secure Payments

Tender Details

  • Country: Russia
  • Summary: Delivery of a Drug for Medical Use (Mnn: Dioxomethyltetrahydropyricimidine+Chloramphenicol)
  • RUT Ref No: 114060819
  • Deadline: 07 Feb 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 877065.60
  • Notice Type: Tender
  • Document Ref. No.: 0818500000825000273
  • Purchaser's Detail :
  • Purchaser : STATE STATE INSTITUTION OF THE KRASNODAR TERRITORY "DIRECTORATE OF STATE PROCUREMENT
    350000, Krasnodar Territory, Krasnodar, st. Krasnaya, D. 35
    F.I.O:- Syrytsina M. N.
    Contact phone number:- 8-861-2115453
    fax:- information is absent
    Email :m.syrytsyna@dgz.krasnodar.ru

  • Description :
  • Delivery of a drug for medical use (MNN: dioxomethyltetrahydropyricimidine+chloramphenicol)
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us